Candriam S.C.A. Red Hill Biopharma Ltd. Transaction History

Candriam S.C.A.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$0.63 - $2.58 $44,898 - $183,868	-71,267 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$2.31 - $5.85 $26,001 - $65,847	-11,256 Reduced 13.64%	71,267 $184,000
Q2 2020 Jul 23, 2020	BUY	$4.6 - $8.6 $51,777 - $96,801	11,256 Added 15.79%	82,523 $553,000
Q3 2017 Nov 03, 2017	BUY	$8.25 - $10.81 $587,952 - $770,396	71,267	71,267 $770,000

40.4K

Ticker RDHL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 63,823,500
Market Cap $452M
Description
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for...

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

Stay updated on Candriam S.C.A. with notifications on news.